BPA Call 36C24222A0007-36C24225N0248

Award Date 11/17/24
Potential Completion Date 11/16/25
Potential Value $120K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Phoenix, AZ 85085, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $187,606.76 Firm Fixed Price Purchase Order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is for the emergency mixing of chemotherapy compounds to support VA oncology and infusion treatment programs nationwide. Avella will perform the work at its own facilities while partnering with various VA Veterans Integrated Service...
This federal contract award, valued at $230,297.50, was issued by the Department of Veterans Affairs Veterans Health Administration (VA-VHA) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is for the delivery of sterile compound supply services to support VA oncology and infusion treatment programs nationwide. As the prime contractor, Avella Specialty Pharmacy will compound customized chemotherapy and other...
This federal contract award to Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy), a subsidiary of UnitedHealth Group Incorporated, is for PHARMACY COMPOUNDING services valued at $1,105,798.44. The contract supports the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) and is a Delivery Order under a Firm Fixed Price contract type. Avella, a 503A certified pharmacy, will provide specialized pharmaceutical compounding services, including chemotherapy...
The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $1,283,466.63 firm fixed price purchase order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, for patient-specific chemotherapy compounding services. Avella, a subsidiary of UnitedHealth Group Incorporated, will provide specialized pharmacy services to support VA oncology and infusion treatment programs nationwide. The award is not associated with a set-aside designation. Avella has...
This is a $458,800.00 firm fixed-price purchase order contract awarded to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, by the Department of Veterans Affairs' Veterans Integrated Service Network 2. The contract is for the provision of short-term chemotherapy and other specialized pharmaceutical compounding services to support the VA's oncology and infusion treatment programs. Optum Pharmacy 801, Inc., operating as Avella Specialty Pharmacy, is a 503A certified...
This federal contract award to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, is for the provision of custom dosed chemotherapy intravenous (IV) medications to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $132,504.84 firm fixed price purchase order has a period of performance through June 30, 2024. Avella Specialty Pharmacy is a subsidiary of UnitedHealth Group Incorporated and operates as a 503A certified pharmacy, specializing...
This federal contract award, valued at $135,000.00, was issued by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The contract is for the provision of chemotherapy compound chemical mix services, under an Indefinite Delivery Contract (IDC) or Blanket Purchase Agreement (BPA) arrangement. Optum Pharmacy 801, Inc., operating as Avella Specialty Pharmacy, is a 503A...
This is a federal delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is for the provision of compounded chemotherapy base and other specialized pharmaceutical services, primarily to support the VA's Veterans Health Administration. The total ceiling value of the contract is $79,558.20, with a period of performance ending on...
This is a $55,205.54 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, to provide custom-dosed chemotherapy IV medications for the VA Baltimore Medical Center. The contract has a performance period through June 30, 2025. This requirement was competed on a full and open basis, without any set-aside designations. Optum Pharmacy 801, Inc., operating as Avella Specialty Pharmacy, has...
The U.S. Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $216,982.32 firm fixed-price definitive contract for compounding services to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract, which has no set-aside designation, was awarded on December 26, 2019 with a completion date of December 25, 2020. As the prime contractor, Avella Specialty Pharmacy will provide specialized...
  • 36C24222A0007
    Blanket Purchase Agreement
  • 36C24222A0007-36C24225N0248
    BPA Call

This firm fixed-price federal contract was awarded by the Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The $120,000.00 contract is for chemotherapy compound services, primarily to support VA oncology and infusion treatment programs nationwide. Avella Specialty Pharmacy will provide specialized pharmaceutical services, including the preparation of customized chemotherapy agents, hazardous sterile preparations, and intravenous solutions, to VA medical centers and clinics.

This contract is part of a larger portfolio of Indefinite Delivery Vehicles (IDVs) held by UnitedHealth Group subsidiaries with the VA, including a $10 million Indefinite Delivery Contract (IDC) for pharmacy compounding services and a $4 million IDC for contingency hazardous pharmaceutical compounding. These IDVs allow the VA to issue task orders as needed to rapidly obtain the specialized pharmaceutical services required to support critical healthcare needs for veterans. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 3/20/25, 10:45 AM